Cerus Corporation Announces Multiple In-Country Regulatory Approvals for INT200 - Next-Generation INTERCEPT Illumination Device

Stock Information for Cerus Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cerus Corporation

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update
Cerus Corporation Celebrates World Blood Donor Day 2025
Cerus Corporation to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
Cerus Corporation Presents Clinical Data for INTERCEPT Blood System at the 35th Regional International Society of Blood Transfusion Congress in Milan
Cerus Corporation Announces First Quarter 2025 Financial Results
Cerus Corporation to Release First Quarter 2025 Financial Results on May 1, 2025
Cerus Corporation Announces Receipt of CE Mark for Next-Generation INTERCEPT Illumination Device (INT200)
Cerus Corporation Announces Full-Year and Fourth Quarter 2024 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.